Skip to content
Current Assets

Other current assets

Moderna Other current assets increased by 13.3% to $51M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.1%, from $69M to $51M. Over 5 years (FY 2020 to FY 2025), Other current assets shows an upward trend with a 16.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026
Metric ID: current_assets_other_assets_current

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$38M$43M$5M$36M$76M$85M$44M$64M$53M$96M$88M$68M$31M$46M$38M$69M$57M$56M$45M$51M
QoQ Change+13.2%-88.4%+620.0%+111.1%+11.8%-48.2%+45.5%-17.2%+81.1%-8.3%-22.7%-54.4%+48.4%-17.4%+81.6%-17.4%-1.8%-19.6%+13.3%
YoY Change+100.0%+97.7%+780.0%+77.8%-30.3%+12.9%+100.0%+6.3%-41.5%-52.1%-56.8%+1.5%+83.9%+21.7%+18.4%-26.1%
Range$5M$96M
CAGR+6.4%
Avg YoY Growth+68.3%
Median YoY Growth+15.7%

Frequently Asked Questions

What is Moderna's other current assets?
Moderna (MRNA) reported other current assets of $51M in Q1 2026.
How has Moderna's other current assets changed year-over-year?
Moderna's other current assets decreased by 26.1% year-over-year, from $69M to $51M.
What is the long-term trend for Moderna's other current assets?
Over 5 years (2020 to 2025), Moderna's other current assets has grown at a 16.5% compound annual growth rate (CAGR), from $21M to $45M.